False Claims Act - G2 Intelligence

SCOTUS Ruling May Save Labs from Baseless Qui Tam Lawsuits

The recent 8-1 decision expands the DOJ’s power to request such cases be thrown out.

A recent SCOTUS ruling on a healthcare fraud case could help defend labs against baseless whistleblower cases.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Last month’s key cases involved the outcome of a UHC lawsuit and fines for misleading claims about a COVID-19 test.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Ruling could spell good news for labs and other healthcare providers targeted by whistleblowers in False Claims Act qui tam lawsuits.

Start a Free Trial for immediate access to this article

Already a member? Log in here

False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.

Start a Free Trial for immediate access to this article

Already a member? Log in here